CERo Therapeutics

CERO

CERO CERo Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CERO Chart
    See on advanced chart >

    About

    CERo Therapeutics Holdings, Inc. was incorporated in Delaware on September 23, 2016. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach...
    • Highlight
      An innovative cancer immunotherapy company
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      11/26/2021
    • Established Date
      09/23/2016
    • Full-time Employees
      8
    • Address
      201 Haskings Way Suite 230 South San Francisco CA 94080
    • Tel
      1-215-7319450
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-18 10:30:35